Buzzy Distraction During Venipuncture
Randomized Controlled Trial to Compare Buzzy and Hand-held Computer Distraction for Pain Control in Children Underwent Venipuncture.
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
Venipuncture is one of the most common iatrogenic painful and stressful procedures performed on children. Interventions aimed at reducing the distress related to this experience are widely and strongly recommended. Pain and anxiety management is even more essential because it may modify children's memory for procedural pain and the subsequent acceptance of later health care painful interventions. Distraction is the most studied psychological technique to relieve venipuncture related pain and distress, with a strong evidence supporting its efficacy in children and adolescents. In recent years several studies showed the effectiveness of a specific tool named Buzzy® (MMJ Labs, Atlanta GA, USA), in relieving pain and distress in children. Buzzy combines distraction and physical analgesia (vibration and cold) and it was positively tested during venipuncture, intravenous cannulation and painful injections in children. Even though its efficacy it's well established, most of the published trials did not compare Buzzy with other interventions, so that little data are available about its usefulness compared with other distractions techniques. Hand-held computers are reusable tools, which offer a technological-based active distraction. There is evidence supporting their used during painful procedures such as venipuncture and a recent published study showed that hand-held computer distraction was as effective as nurse-led passive distraction techniques in children. The aim of this study is to compare the effectiveness of Buzzy versus hand-held computer in pain relief during venipuncture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2014
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 17, 2016
CompletedFirst Posted
Study publicly available on registry
November 21, 2016
CompletedAugust 21, 2017
August 1, 2017
3 months
November 17, 2016
August 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-reported pain
Children from 4 to 7 years of age record their pain using the Faces Pain Scale-Revised (FPS-R); children from 8 to 12 years using a Numerical Rating Scale, with scores from zero to 10.
Within 5 minutes after the procedure
Secondary Outcomes (4)
Pain evaluated by parents
Within 5 minutes after the procedure
Pain evaluated by nurses
Within 5 minutes after the procedure
Success at first attempt
Intraprocedural
Adverse events
Up to 15 minutes after the procedure
Study Arms (2)
Buzzy® device
EXPERIMENTALThe Buzzy® device is applied just above the selected site of the venipuncture; an ice pack is attached under the device; the device is turned on and after 15 second the venipuncture is made.
Hand-held computer
ACTIVE COMPARATORUsing an hand-held computer, children start to play with an age-appropriate videogame three minutes before the procedure. They continue to play during the venipuncture.
Interventions
Eligibility Criteria
You may qualify if:
- children from 4 to 12 years of age needing venipuncture
You may not qualify if:
- the presence of damage, denuded or broken skin in the site of Buzzy application;
- use of topical, enteral or parenteral analgesics within eight hours before enrolment;
- the presence of cognitive impairment or the inability to report pain verbally;
- the presence of chronic disease, included epilepsy, or of diseases associated with cold hypersensitivity (i.e., sickle cell anaemia, Raynaud's disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Egidio Barbi, MD
IRCCS Burlo Garofolo
- STUDY DIRECTOR
Franca Crevatin, RN
IRCCS Burlo Garofolo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Clinical Epidemiology and Public Health Research Unit
Study Record Dates
First Submitted
November 17, 2016
First Posted
November 21, 2016
Study Start
November 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
August 21, 2017
Record last verified: 2017-08